The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer

BACKGROUND: Sunitinib is widely used as first-line treatment for metastatic clear cell renal cancer (MCRC). No reports are known of treatment after sunitinib failure. As irinotecan, cisplatin, and mitomycin-C (IPM) chemotherapy has been reported to influence MCRC after progression on cytokine therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Powles, Thomas, McFaul, Siobhan, Stebbing, Justin, Wilson, Peter, Oliver, Tim, Tranter, Naomi, Shamash, Jonathan
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994212/
https://www.ncbi.nlm.nih.gov/pubmed/21127750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994212/
https://www.ncbi.nlm.nih.gov/pubmed/21127750

Ejemplares similares